Clovis Oncology, Inc.
Clovis Oncology, Inc. (CLVS) is a publicly traded company in the Unknown sector. Across all available filings, 35 corporate insiders have executed 1000 transactions totaling $245.8M, demonstrating a bullish sentiment with $145.8M in net insider flow. The most recent transaction on Nov 2, 2022 involved a sale of 1,908 shares valued at $1.9K.
CLVS Insider Activity Summary
Who Is Buying CLVS Stock?
No significant insider buying has been recorded for CLVS in the recent period.
Who Is Selling CLVS Stock?
No significant insider selling has been recorded for CLVS in the recent period.
Is Clovis Oncology, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CLVS is bullish with an Insider Alignment Score of 80/100 and a net flow of $145.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CLVS Frequently Asked Questions
Understanding CLVS Insider Activity
Insider trading at Clovis Oncology, Inc. (CLVS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 35 insiders are actively trading CLVS stock, having executed 1000 transactions in the past 90 days. The most active insider is Parters VII L. P. Domain (Executive), who has made 6 transactions totaling $22.2M.
Related Tools
Track Clovis Oncology, Inc. Insider Activity
Get notified when executives and directors at CLVS file new Form 4 transactions